SMMT

Summit Therapeutics Inc.

Tremor tracks 6 of its cancer trials.

Company-wide warning signs

These add points to every one of this company's trials.

None right now.

Trials

SMMTSummit Therapeutics
10Calm
Phase III Study of AK112 for NSCLC Patients
Running, no new patientsPhase 3420 patientsMain results: Apr 12, 2025
SMMTSummit Therapeutics
0Calm
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Signing up patientsPhase 3900 patientsMain results: May 31, 2028
SMMTSummit Therapeutics
0Calm
A Clinical Study of Ivonescimab in Combination With Cadonilimab or Ipilimumab for Advanced Renal Cancer
Not started yetPhase 2100 patientsMain results: Apr 12, 2029
SMMTSummit Therapeutics
0Calm
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Running, no new patientsPhase 31,600 patientsMain results: Dec 31, 2028
SMMTSummit Therapeutics
0Calm
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Signing up patientsPhase 3780 patientsMain results: Apr 2028
SMMTSummit Therapeutics
0Calm
A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma
Signing up patientsPhase 2/3800 patientsMain results: Oct 31, 2030

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

0 sales (0 not pre-planned) · 6 purchases

Zanganeh MahkamCo-Chief Executive Officer · Jun 12, 2026Bought 3,810,000 sharesabout $50.0 million ·
DUGGAN ROBERT WCo-Chief Executive Officer · Jun 12, 2026Bought 3,810,000 sharesabout $50.0 million ·
DUGGAN ROBERT WCo-Chief Executive Officer · Jun 4, 2026Bought 100,000 sharesabout $1.5 million ·
Zanganeh MahkamCo-Chief Executive Officer · Jun 4, 2026Bought 100,000 sharesabout $1.5 million ·
Soni Manmeet SinghCOO and CFO · Jun 4, 2026Bought 25,000 sharesabout $362 thousand ·
Soni Manmeet SinghCOO and CFO · Jun 4, 2026

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.